Therapy Areas: Vaccines
India's Bharat Biotech resumes exports of domestic COVID-19 vaccine
29 November 2021 -

Indian biotechnology company and vaccine maker Bharat Biotech International Limited (Bharat Biotech) has resumed export of its COVID-19 shot, Covaxin, and has executed long-pending orders in November 2021, Reuters news agency reported on Monday.

According to a statement on Twitter, the company also said exports to additional countries will commence from December 2021.

However, it was not immediately clear whether or not these exports were made under the global vaccine-sharing facility COVAX.

Covaxin, which is 78% effective against severe cases of COVID-19, was approved for emergency use listing by the World Health Organisation earlier this month.

On 26 November 2021, India restarted exports of COVID-19 shots to COVAX for the first time since April 2021.



Related Headlines